Global Open Loop Artificial Pancreas Market Growth 2025-2031

The global Open Loop Artificial Pancreas market size is predicted to grow from US$ 1612 million in 2025 to US$ 2551 million in 2031; it is expected to grow at a CAGR of 8.0% from 2025 to 2031.

Open loop artificial pancreas is a relatively simple but effective medical device for diabetes management. Its core function is to simulate the insulin secretion mechanism of healthy pancreas. Unlike closed-loop systems, open-loop artificial pancreas does not have blood glucose sensors, but is mainly composed of two core parts: a microcomputer and an insulin injection pump. This system design simplifies its structure, reduces its size, and makes it easier for patients to carry and use. The operating mechanism of open-loop artificial pancreas is based on preset programs rather than real-time blood glucose monitoring data. The patient's blood glucose concentration data needs to be manually input into the system, and the microcomputer calculates the insulin dose and rate parameters that need to be infused based on these input data and preset algorithms. Subsequently, the insulin injection pump automatically injects the corresponding amount of insulin into the patient's body according to the calculated parameters.

The global open loop artificial pancreas market has maintained a growth trend in recent years. With the acceleration of the aging process of the population and the change of lifestyle, the number of patients with diabetes has increased rapidly, providing a huge potential demand for artificial pancreas. The technological breakthroughs in the field of artificial pancreas are mainly reflected in miniaturization, intelligence, and materials science, which indirectly promote the improvement and upgrading of open-loop systems. The changes in medical policies and reimbursement systems have a profound impact on the market landscape. In many developed countries, artificial pancreas is included in the coverage of medical insurance, which greatly reduces the economic burden on patients and promotes the increase of market penetration. With the popularization of health education and the wide spread of medical information, diabetes patients began to seek more accurate and convenient blood glucose management solutions. The open-loop artificial pancreas is between traditional injection and fully automated closed-loop systems, balancing performance and price, and has become the choice of many patients. The global market competition pattern is relatively clear, with multiple companies engaging in fierce competition. Tandem Diabetes Care, Johnson&Johnson, Medtronic and other companies form the forefront of the industry. They occupy an important position with their strong research and development capabilities, mature production capabilities, and extensive sales network. The focus of competition between enterprises is gradually shifting from simple device performance to the provision of overall solutions, including multiple dimensions such as supporting software, data services, and user experience. Open loop artificial pancreas is a relatively mature product, and its technological development mainly focuses on improving the accuracy, reliability, and user friendliness of the system, while striving to reduce production costs and maintenance complexity. The introduction of intelligent functions and algorithm optimization is changing the user experience of traditional open-loop systems. The development of future biotechnology may bring about new insulin delivery mechanisms, and breakthroughs in materials science may enable longer lasting implantable components, reducing equipment maintenance requirements. The advancement of energy technology may give rise to ultra long battery life or even self powered systems, greatly improving user convenience. New products such as patch insulin delivery devices and wearable integrated devices will further simplify the usage process and reduce interference with patients' daily lives. In addition, integration with the digital health ecosystem, innovation in manufacturing processes, and finding exclusive market positioning are also the development trends of future products.

LP Information, Inc. (LPI) ' newest research report, the “Open Loop Artificial Pancreas Industry Forecast” looks at past sales and reviews total world Open Loop Artificial Pancreas sales in 2024, providing a comprehensive analysis by region and market sector of projected Open Loop Artificial Pancreas sales for 2025 through 2031. With Open Loop Artificial Pancreas sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Open Loop Artificial Pancreas industry.

This Insight Report provides a comprehensive analysis of the global Open Loop Artificial Pancreas landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Open Loop Artificial Pancreas portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Open Loop Artificial Pancreas market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Open Loop Artificial Pancreas and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Open Loop Artificial Pancreas.

This report presents a comprehensive overview, market shares, and growth opportunities of Open Loop Artificial Pancreas market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Basic Insulin Pump System
CGM Insulin Pump Linkage System
Threshold Pause System

Segmentation by Application:
Type 1 Diabetes Management
Type 2 Diabetes Intensive Treatment
Clinical Research Transitional Stage

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Roche
Insulet
Tandem Diabetes Care
Johnson And Johnson
Abbott Laboratories
Ypsomed
Dexcom
Medtronic
Medtrum Technologies
MicroTech Medical
Sansure Medical
Medlinket Medical Technology
SiBionics

Key Questions Addressed in this Report

What is the 10-year outlook for the global Open Loop Artificial Pancreas market?

What factors are driving Open Loop Artificial Pancreas market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Open Loop Artificial Pancreas market opportunities vary by end market size?

How does Open Loop Artificial Pancreas break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.